LCGC
TMO icon

Legacy Capital Group California’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Capital Group California’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,890
Closed -$940K – 354
2025
Q1 		$940K Sell
1,890
-9
-0.5% -$4.87K 0.33% 68
2024
Q4 		$988K Buy
+1,899
New +$1.04M 0.3% 74

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Legacy Capital Group California's TMO Position: Q2 2025 in Review

Legacy Capital Group California sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 1,890 shares — an estimated $940K sold.

Legacy Capital Group California first reported a position in TMO in Q4 2024 and held it in 2 quarters. The position peaked at $988K in Q4 2024. 2,459 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Legacy Capital Group California reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Legacy Capital Group California sold 1,890 Thermo Fisher Scientific shares in Q2 2025, an estimated $940K.
  • Legacy Capital Group California first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 2 quarters.
  • Legacy Capital Group California's Thermo Fisher Scientific position peaked at $988K in Q4 2024.
  • 2,459 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Legacy Capital Group California's 13F filing for Q2 2025, filed 14 Jul 2025.